Berlin - Delayed Quote EUR
Lineage Cell Therapeutics Inc (BT3.BE)
0.3840
+0.0100
+(2.67%)
As of 8:08:23 AM GMT+2. Market Open.
Loading Chart for BT3.BE
- Previous Close
0.3740 - Open
0.3840 - Bid 0.3920 x --
- Ask 0.4060 x --
- Day's Range
0.3840 - 0.3840 - 52 Week Range
0.3340 - 1.0700 - Volume
0 - Avg. Volume
50 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: BT3.BE
View MorePerformance Overview: BT3.BE
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
BT3.BE
16.88%
S&P 500 (^GSPC)
3.02%
1-Year Return
BT3.BE
66.32%
S&P 500 (^GSPC)
9.95%
3-Year Return
BT3.BE
65.81%
S&P 500 (^GSPC)
38.33%
5-Year Return
BT3.BE
55.40%
S&P 500 (^GSPC)
94.69%
Compare To: BT3.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BT3.BE
View MoreValuation Measures
As of 5/7/2025
Market Cap
89.40M
Enterprise Value
49.46M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.94
Price/Book (mrq)
1.24
Enterprise Value/Revenue
5.91
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--